How FDA’s New Real-World Data Guidance Solves 3 Big Problems
In case you missed it, at the end of August, the FDA released new guidance on how to approach...
HealthVerity Blog
- Read the latest insights from the HealthVerity team.
Search
Category
Popular Post
- The GLP-1 trend: What the real-world data reveals
- GLP-1 trends 2025: real-world data, patient outcomes & future therapies
- Open claims vs. closed payer claims: What’s the difference?
- GLP‑1 real‑world data for obesity: A new standard for metabolic care
- What is Privacy Preserving Record Linkage (PPRL)?
Subscribe
The future of multiple sclerosis: Progression focused therapies and RWE
Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system (CNS) and can lead to significant disability over time. It remains the most common inflammatory neurological condition worldwide and in the United States alo...